e-learning
resources
Virtual 2020
Pre-Congress Content
Health effects of inhaled nicotine devices: from smoking to vaping and heated tobacco
Login
Search all ERS
e-learning
resources
COVID-19
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
Global Lung Function Initiative
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
COVID-19
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Diffuse Alveolar Hemorrhage: a life-threatening adverse effect of vaping
D. Ambrozej (Warsaw, Poland), T. Bielecka (Warsaw, Poland), W. Feleszko (Warsaw, Poland), K. Krenke (Warsaw, Poland)
Source:
Virtual Congress 2020 – Health effects of inhaled nicotine devices: from smoking to vaping and heated tobacco
Session:
Health effects of inhaled nicotine devices: from smoking to vaping and heated tobacco
Session type:
E-poster session
Number:
1871
Disease area:
Interstitial lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
D. Ambrozej (Warsaw, Poland), T. Bielecka (Warsaw, Poland), W. Feleszko (Warsaw, Poland), K. Krenke (Warsaw, Poland). Diffuse Alveolar Hemorrhage: a life-threatening adverse effect of vaping. 1871
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Interstitial lung disease (ILD) and multicompartment assessment of CTD: where should the respiratory physician begin?
Does “UIPAF” really exist?
COVID-19 and the management of Interstitial Lung Diseases patients: challenges and recommendations
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept